Erdafitinib,Vinflunine,Docetaxel,Pembrolizumab
Janssen,pierre fabre,Merck
['urothelial carcinoma', 'urothelial', 'erdafitinib']
erdafitinib improves survival vs chemotherapy in patients with metastatic urothelial carcinoma and select fgfr alterations who were previously treated with immune checkpoint inhibitors, a phase 3 trial presented at asco 2023 suggests. #asco23 
https://t.co/bi63MIVP5D is a resource offering oncology health care professionals practical information about the changing clinical landscape.